Reserpine augmentation of desipramine in refractory depression: clinical and neurobiological effects
Authors:
- 1 August 1987
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 92 (4) , 431-437
Abstract
Early studies showed dramatic improvement in some depressed patients when a brief course of parenteral reserpine was added to ineffective tricyclic antidepressant (TCA) treatment. We treated eight patients with DSM-III melancholic major depression with desipramine (DMI)≥2.5 mg/kg/day (plasma levels>125 ng/ml) for at least 4 weeks. All patients failed to respond and received reserpine 5 mg IM b.i.d. over 2 days, in seven cases as a placebo-controlled, double-blind trial. One patient had dramatic resolution of depressive and psychotic symptoms within 48 h, but relapsed within 2 weeks; two other patients had transient hypomanic symptoms. Depression ratings did not significantly change for the sample as a whole, but plasma and cerebrospinal fluid (CSF) levels of 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) decreased and CSF levels of homovanillic acid (HVA) and 5-hydroxy-indoleacetic acid (5-HIAA) increased. Despite robust effects on central monoamine metabolism, reserpine augmentation appears insufficiently effective for routine use in managing refractory depression.Keywords
This publication has 40 references indexed in Scilit:
- CSF monoamine metabolites in melancholiaActa Psychiatrica Scandinavica, 1984
- Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioningPharmacology & Therapeutics, 1983
- The effect of long-term lithium treatment on reserpine-induced supersensitivity in dopaminergic and serotonergic transmissionLife Sciences, 1979
- Treatment with Reserpine of Patients Resistant to Tricyclic AntidepressantsPsychopathology, 1975
- Regulation of Norepinephrine BiosynthesisAnnual Review of Pharmacology, 1970
- Effect of Imipramine, Amitriptyline and Their Monomethyl Derivatives on Reserpine ActivityJournal of Pharmacy and Pharmacology, 1962
- Desmethylimipramine, a New Type of Antidepressant DrugPharmacology, 1961
- Five-Year Follow-Up of Results of Reserpine Therapy in Mental Hospital PracticeJournal of Mental Science, 1960
- CHLORPROMAZINE AND RESERPINE IN THE TREATMENT OF PSYCHOSESAnnals of the New York Academy of Sciences, 1955
- CLINICAL EFFECTIVENESS OF RESERPINEAnnals of the New York Academy of Sciences, 1955